Suppr超能文献

CCT3和CCT7顶端结构域对tau蛋白聚集的抑制作用。

Inhibition of tau aggregation by the CCT3 and CCT7 apical domains.

作者信息

Ben-Maimon Miki, Elad Nadav, Naveh-Tassa Segev, Levy Yaakov, Horovitz Amnon

机构信息

Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.

Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.

出版信息

Protein Sci. 2025 Jun;34(6):e70162. doi: 10.1002/pro.70162.

Abstract

The eukaryotic chaperonin containing t-complex polypeptide 1 (CCT/TRiC) is a molecular chaperone that assists protein folding in an ATP-driven manner. It consists of two stacked identical rings that are each made up of eight distinct subunits. Here, we show that the apical domains of subunits CCT3 and CCT7 from humans are strong inhibitors of tau aggregation, which is associated with several neurological disorders such as Alzheimer's and Parkinson's diseases. Kinetic analyses and negative-stain electron microscopy indicate that the mechanism of inhibition of tau aggregation by the apical domains of subunits CCT3 and CCT7 differ. Aggregation of tau alone, or in the presence of the apical domain of subunit CCT7, can be described by a fragmentation model whereas in the presence of the apical domain of subunit CCT3, it fits a saturating elongation and fragmentation mechanism. Coarse-grained molecular dynamics simulations show that tau interacts with different regions in the apical domains of subunits CCT3 and CCT7, in agreement with their different inhibition mechanisms.

摘要

真核生物中含t-复合体多肽1的伴侣蛋白(CCT/TRiC)是一种分子伴侣,它以ATP驱动的方式协助蛋白质折叠。它由两个堆叠的相同环组成,每个环由八个不同的亚基构成。在此,我们表明人类亚基CCT3和CCT7的顶端结构域是tau蛋白聚集的强效抑制剂,tau蛋白聚集与多种神经疾病相关,如阿尔茨海默病和帕金森病。动力学分析和负染电子显微镜表明,亚基CCT3和CCT7的顶端结构域抑制tau蛋白聚集的机制不同。单独的tau蛋白聚集,或在亚基CCT7顶端结构域存在的情况下,可用碎片化模型描述,而在亚基CCT3顶端结构域存在的情况下,它符合饱和延伸和碎片化机制。粗粒度分子动力学模拟表明,tau蛋白与亚基CCT3和CCT7顶端结构域的不同区域相互作用,这与其不同的抑制机制一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验